morpholinoanthracycline mx2 has been researched along with me 2303 in 2 studies
| Studies (morpholinoanthracycline mx2) | Trials (morpholinoanthracycline mx2) | Recent Studies (post-2010) (morpholinoanthracycline mx2) | Studies (me 2303) | Trials (me 2303) | Recent Studies (post-2010) (me 2303) |
|---|---|---|---|---|---|
| 53 | 15 | 0 | 23 | 1 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, I; Kiura, K; Ohnoshi, T; Takigawa, N; Ueoka, H | 1 |
| Ariyoshi, Y; Ogawa, M | 1 |
1 review(s) available for morpholinoanthracycline mx2 and me 2303
| Article | Year |
|---|---|
[New anthracyclines].
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Carubicin; Doxorubicin; Humans; Idarubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Menogaril; Stomach Neoplasms | 1993 |
1 trial(s) available for morpholinoanthracycline mx2 and me 2303
| Article | Year |
|---|---|
[New anthracyclines].
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Carubicin; Doxorubicin; Humans; Idarubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Menogaril; Stomach Neoplasms | 1993 |
1 other study(ies) available for morpholinoanthracycline mx2 and me 2303
| Article | Year |
|---|---|
Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Carubicin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Molecular Structure; Tumor Cells, Cultured | 1992 |